(Q30341657)

20 June 2017

title

Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use. (English)

1 reference

20 June 2017

0 references

0 references

1 reference

Hehme N

1

1 reference

20 June 2017

Engelmann H

2

1 reference

20 June 2017

Kuenzel W

3

1 reference

20 June 2017

Neumeier E

4

1 reference

20 June 2017

Saenger R

5

1 reference

20 June 2017

publication date

1 July 2004

1 reference

20 June 2017

1 reference

20 June 2017

volume

103

1 reference

20 June 2017

issue

1-2

1 reference

20 June 2017

page(s)

163-171

1 reference

Influenza vaccination in 29 countries. An update to 1997.

20 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.029

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.029

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.029

Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.029

Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.029

Identification and Preliminary Antigenic Analysis of Swine Influenza-Like Viruses Isolated during an Influenza Outbreak at Fort Dix, New Jersey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.029

Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.029

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.029

Human infection with influenza H9N2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.029

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.029

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.029

Selection of influenza vaccine strains and developing pandemic vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.029

Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.029

10.1016/J.VIRUSRES.2004.02.029

7 January 2021

Identifiers

DOI

1 reference

20 June 2017

1 reference